FDA NDC Directory · JSON-LD · Markdown

Rivastigmine Tartrate

NDC 62332-063 · HUMAN PRESCRIPTION DRUG · CAPSULE

Labeler / ManufacturerAlembic Pharmaceuticals Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA091689
Dosage form / routeCAPSULE · ORAL
Active ingredientsRIVASTIGMINE TARTRATE (1.5 mg/1)
Marketing started20220612
Package count5

External sources

Source: openFDA. Public-domain (CC0).